高视医疗(02407.HK) 发盈警，预计2024年度利润净额介乎8,020万至8,860万人民币，按年减少约48.8%-53.6%。主要受汇率波动、人工晶体国采政策执行等因素的影响，综合毛利率降低，使得毛利润减少；预期对附属相关现金产生单元录得商誉计提减值拨备，估计金额介乎2,210万至2,450万人民币；研发开支显著增加；及出现汇兑损失。(de/d)(港股报价延迟最少十五分钟。)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2024/08/28 | 中期业绩 | 无派息 |
| 2024/03/25 | 末期业绩 | 股息：港元 1.1000 |
| 2023/08/24 | 中期业绩 | 无派息 |
| 2023/03/31 | 末期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.